Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Book/Report

Opioids in Medicare Part D: Concerns About Extreme Use and Questionable Prescribing.

Opioids in Medicare Part D: Concerns About Extreme Use and Questionable Prescribing. Office of the Inspector General. Washington, DC: US Department of Health and Human Services; July 2017. Report No. OEI-02-17-00250.

Save
Print
August 9, 2017
Office of the Inspector General. Washington, DC: US Department of Health and Human Services; July 2017. Report No. OEI-02-17-00250.

Misuse of prescription opioids represents a serious patient safety issue. This data brief reviews federal Medicare statistics on opioid use by older Americans to highlight patient behaviors and provider prescribing patterns that could indicate, contribute to, or perpetuate unsafe opioid use.

Save
Print
Cite
Citation

Opioids in Medicare Part D: Concerns About Extreme Use and Questionable Prescribing. Office of the Inspector General. Washington, DC: US Department of Health and Human Services; July 2017. Report No. OEI-02-17-00250.